Table 3. Univariable and Multivariable Linear Regression Analysis of EDVi and ESVi in Patients with PA (n = 35).
EDVi (R2 = 0.364) | ESVi (R2 = 0.102) | |||||||
---|---|---|---|---|---|---|---|---|
Univariable | Multivariable | Univariable | Multivariable | |||||
β | P | β | P | β | P | β | P | |
Age, years | 0.141 | 0.419 | 0.182 | 0.296 | ||||
Sex | 0.180 | 0.301 | 0.089 | 0.611 | ||||
BMI, kg/m2 | −0.061 | 0.728 | 0.009 | 0.959 | ||||
SBP, mm Hg | 0.435 | 0.009 | 0.303 | 0.041 | 0.120 | 0.494 | ||
DBP, mm Hg | 0.281 | 0.102 | 0.028 | 0.874 | ||||
Ald, ng/dL | 0.212 | 0.222 | 0.187 | 0.282 | ||||
logARR | 0.458 | 0.006 | 0.338 | 0.024 | 0.359 | 0.034 | 0.359 | 0.034 |
Serum potassium, mmoL/L | −0.197 | 0.258 | −0.190 | 0.274 | ||||
Hypertension course, months | 0.410 | 0.014 | 0.326 | 0.025 | 0.348 | 0.041 | 0.307 | 0.060 |
Ald = aldosterone, ARR = plasma aldosterone-to-renin ratio, BMI = body mass index, DBP = diastolic blood pressure, EDVi = left ventricular end-diastolic volume index, ESVi = left ventricular end-systolic volume index, PA = primary aldosteronism, SBP = systolic blood pressure